Medray Group | LDC | DCM
DunPort supports LDC in its investment in Medray Group
DunPort Capital Management are delighted to provide debt facilities to support LDC, the private equity investor, in its investment into healthcare equipment and service provider, Medray Group. The transaction marks an exit for Irish private equity investor, Erisbeg and is subject to the approval of the Competition and Consumer Protection Commission (CCPC) in Ireland.
Medray is a leading provider of diagnostic imaging equipment, including X-ray and CT, to customers across the healthcare, veterinary and dental markets in the UK and Ireland. It supplies, installs and services equipment for c. 2,700 customers, in addition to providing complementary products and accessories. Medray, led by Siobhán Crowley, employs 120 people – split between its Dublin base and a distribution centre in Hemel Hempstead.
LDC were advised by Clearwater (M&A / Debt Advisory), Addleshaw Goddard (Legal), KPMG (Financial and Tax Due Diligence), and Candesic (Commercial Due Diligence). DunPort Capital were advised by Eversheds Sutherland (Legal), and erisbeg were advised by Deloitte, EY, Mansfield Advisors, ReganWall and Mathesons.
Medray represents DunPort’s seventh deal of 2024, the 19th company to have been supported by the Oak Corporate Credit Fund, DunPort’s €335m lending vehicle, and the 65th unique company which DunPort has supported overall.
